Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice
Johannes Grosse, … , Michael Nehls, Bernhard Nieswandt
Johannes Grosse, … , Michael Nehls, Bernhard Nieswandt
Published October 25, 2007
Citation Information: J Clin Invest. 2007;117(11):3540-3550. https://doi.org/10.1172/JCI32312.
View: Text | PDF
Research Article Hematology

An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice

  • Text
  • PDF
Abstract

Changes in cytoplasmic Ca2+ levels regulate a variety of fundamental cellular functions in virtually all cells. In nonexcitable cells, a major pathway of Ca2+ entry involves receptor-mediated depletion of intracellular Ca2+ stores followed by the activation of store-operated calcium channels in the plasma membrane. We have established a mouse line expressing an activating EF hand motif mutant of stromal interaction molecule 1 (Stim1), an ER receptor recently identified as the Ca2+ sensor responsible for activation of Ca2+ release–activated (CRAC) channels in T cells, whose function in mammalian physiology is not well understood. Mice expressing mutant Stim1 had macrothrombocytopenia and an associated bleeding disorder. Basal intracellular Ca2+ levels were increased in platelets, which resulted in a preactivation state, a selective unresponsiveness to immunoreceptor tyrosine activation motif–coupled agonists, and increased platelet consumption. In contrast, basal Ca2+ levels, but not receptor-mediated responses, were affected in mutant T cells. These findings identify Stim1 as a central regulator of platelet function and suggest a cell type–specific activation or composition of the CRAC complex.

Authors

Johannes Grosse, Attila Braun, David Varga-Szabo, Niklas Beyersdorf, Boris Schneider, Lutz Zeitlmann, Petra Hanke, Patricia Schropp, Silke Mühlstedt, Carolin Zorn, Michael Huber, Carolin Schmittwolf, Wolfgang Jagla, Philipp Yu, Thomas Kerkau, Harald Schulze, Michael Nehls, Bernhard Nieswandt

×

Figure 2

T cell function in Stim1Sax/+ mice.

Options: View larger image (or click on image) Download as PowerPoint
T cell function in Stim1Sax/+ mice.
               
(A) Flow cytometric ...
(A) Flow cytometric analysis of the CD4/CD8 distribution among thymocytes and splenocytes. Mean frequencies of cells per quadrant are given ± SD (n = 3 per group). (B) Indo-1–labeled WT (black line) and Stim1Sax/+ (grey line) CD4+ T cells in Ca2+-free medium were left untreated (top), incubated with anti-CD3 antibodies followed by a crosslinking secondary antibody (middle), or stimulated with TG (bottom), and [Ca2+]i levels were monitored. Addition of 0.4 mM extracellular Ca2+ is indicated (Ca2+ arrow). The data shown is representative of more than 6 individual experiments with virtually identical results. (C) CFSE-labeled splenocytes of the indicated genotype were either left unstimulated (dotted line) or stimulated with anti-CD3 mAb in solution (solid line) for 3 days prior to analysis of CFSE dye dilution among CD4+ and CD8+ cells. The numbers indicate the mean percentages of CFSE-low cells ± SD (n = 3 per group). (D) H-2b–primed lymph node cells of WT (closed circles) and StimSax/+ mice (open circles) were used as effector cells (E) against EL-4 target cells (T). Blocking anti-CD8α antibody was added as indicated.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts